Literature DB >> 16644583

Treatment with valproic acid, all-trans retinoic acid (ATRA) and theophyllamine for 9 days caused a persistent increase in peripheral blood platelet counts for a patient with acute myelogenous leukemia.

Camilla Stapnes, Anita Ryningen, Bjørn Tore Gjertsen, Øystein Bruserud.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16644583     DOI： 10.1080/02841860500482233

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  2 in total

1.  Non-genomic activities of retinoic acid receptor alpha control actin cytoskeletal events in human platelets.

Authors:  M T Rondina; M Freitag; F G Pluthero; W H A Kahr; J W Rowley; L W Kraiss; Z Franks; G A Zimmerman; A S Weyrich; H Schwertz
Journal:  J Thromb Haemost       Date:  2016-03-22       Impact factor: 5.824

2.  In Vitro Characterization of Valproic Acid, ATRA, and Cytarabine Used for Disease-Stabilization in Human Acute Myeloid Leukemia: Antiproliferative Effects of Drugs on Endothelial and Osteoblastic Cells and Altered Release of Angioregulatory Mediators by Endothelial Cells.

Authors:  Hilde Kvestad; Lasse Evensen; James B Lorens; Oystein Bruserud; Kimberley J Hatfield
Journal:  Leuk Res Treatment       Date:  2014-01-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.